{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:40:00Z","timestamp":1793972400629,"version":"4.8.0"},"reference-count":594,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"DOI":"10.1210\/er.2011-1034","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T15:21:12Z","timestamp":1354893672000},"page":"981-1030","source":"Crossref","is-referenced-by-count":1668,"title":["Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications"],"prefix":"10.1210","volume":"33","author":[{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"first","affiliation":[{"name":"Medical School, University of Athens (E.D.-K.), Athens GR-14578, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dunaif","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine (A.D.), Chicago, Illinois 60611-3008"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2012,10,12]]},"reference":[{"key":"2019041121392790700_B1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.genom.2.1.435","article-title":"The genetics of aging","volume":"2","author":"Finch","year":"2001","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2019041121392790700_B2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1749-6632.2010.05640.x","article-title":"A pathway that links reproductive status to lifespan in Caenorhabditis elegans","volume":"1204","author":"Kenyon","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"2019041121392790700_B3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/493243","article-title":"Hippocrates: Diseases of Women 1","volume":"1","author":"Hanson","year":"1975","journal-title":"Signs (Chic)"},{"key":"2019041121392790700_B4","article-title":"De Sedibus et Causis Morborum per Anatomen Indagata (The seats and causes of diseases investigated by anatomy)","author":"Morgagni","year":"1765"},{"key":"2019041121392790700_B5","first-page":"51","article-title":"Le virilisme et son association \u00e0 l'insuffisance glycolytique (diab\u00e8te des femmes \u00e0 barbe)","volume":"86","author":"Achard","year":"1921","journal-title":"Bull Acad Natl Med (Paris)"},{"key":"2019041121392790700_B6","first-page":"339","article-title":"La diff\u00e9rentiation sexuelle. Facteur determinant des formes de l'obesit\u00e9","volume":"55","author":"Vague","year":"1947","journal-title":"Presse Med"},{"key":"2019041121392790700_B7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jcem-54-2-254","article-title":"Relation of body fat distribution to metabolic complications of obesity","volume":"54","author":"Kissebah","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jcem-70-2-473","article-title":"Androgen-estrogen metabolism in women with upper body versus lower body obesity","volume":"70","author":"Kirschner","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/edrv-13-3-566","article-title":"Mutations in the insulin receptor gene","volume":"13","author":"Taylor","year":"1992","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (Type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2019041121392790700_B12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B13","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"2019041121392790700_B15","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B16","volume-title":"M\u00e9moires pour servir \u00e0 l'\u00e9tude des malades ovaires","author":"Chereau","year":"1844"},{"key":"2019041121392790700_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1201\/9780203910948.pt1","article-title":"Historical perspectives","volume-title":"Polycystic ovary syndrome","author":"Goldzieher","year":"2002"},{"key":"2019041121392790700_B18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/jcem-22-3-325","article-title":"The polycystic ovary. I. Clinical and histologic features","volume":"22","author":"Goldzieher","year":"1962","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B20","first-page":"3","article-title":"Historical Overview of the Polycystic Ovary","volume-title":"Polycystic ovary syndrome","author":"Givens","year":"1992"},{"key":"2019041121392790700_B21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B22","first-page":"545","article-title":"Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization","volume":"66","author":"Dunaif","year":"1985","journal-title":"Obstet Gynecol"},{"key":"2019041121392790700_B23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diab.34.2.101","article-title":"Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the Type A and B syndromes","volume":"34","author":"Flier","year":"1985","journal-title":"Diabetes"},{"key":"2019041121392790700_B24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","article-title":"Prevalence of facial acne vulgaris in late adolescence and in adults","volume":"1","author":"Cunliffe","year":"1979","journal-title":"Br Med J"},{"key":"2019041121392790700_B26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Derm"},{"key":"2019041121392790700_B27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2265.1994.tb02535.x","article-title":"A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia","volume":"41","author":"O'Driscoll","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2133.2004.06058.x","article-title":"Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a cross-sectional study","volume":"151","author":"Dalgard","year":"2004","journal-title":"Br J Dermatol"},{"key":"2019041121392790700_B31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2133.2005.06527.x","article-title":"Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study","volume":"152","author":"Galobardes","year":"2005","journal-title":"Br J Dermatol"},{"key":"2019041121392790700_B32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clindermatol.2006.04.004","article-title":"Dermatology of androgen-related disorders","volume":"24","author":"Essah","year":"2006","journal-title":"Clin Dermatol"},{"key":"2019041121392790700_B33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1210\/jcem-73-3-590","article-title":"Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings","volume":"73","author":"Dunaif","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B35","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"key":"2019041121392790700_B36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"2019041121392790700_B37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9378(83)90998-5","article-title":"Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism","volume":"146","author":"Wild","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jcem-49-5-730","article-title":"Testosterone binding and free plasma androgen concentrations under physiological conditions: characterization by flow dialysis technique","volume":"49","author":"Moll","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society Position Statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jsbmb.2010.03.032","article-title":"Standardization of testosterone measurements in humans","volume":"121","author":"Vesper","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121392790700_B42","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B43","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"2019041121392790700_B46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-49-6-892","article-title":"Adrenal function in normal women and women with the polycystic ovary syndrome","volume":"49","author":"Lachelin","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9378(75)90081-2","article-title":"Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease","volume":"121","author":"DeVane","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B48","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-45-4-798","article-title":"Pituitary-ovarian relationships in polycystic ovary syndrome","volume":"45","author":"Baird","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B49","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1210\/jcem-27-8-1103","article-title":"Plasma precursors of estrogen. I. Extent of conversion of plasma \u03b4-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females","volume":"27","author":"MacDonald","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1210\/jcem-52-5-868","article-title":"Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions","volume":"52","author":"Moll","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/jcem-52-1-156","article-title":"Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO","volume":"52","author":"Lobo","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B52","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/oxfordjournals.humrep.a138480","article-title":"Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis","volume":"9","author":"Hillier","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B54","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome; towards a rational approach","volume-title":"Polycystic ovary syndrome","author":"Zawadzki","year":"1992"},{"key":"2019041121392790700_B55","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B56","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B57","first-page":"3728","article-title":"Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity","volume":"82","author":"Arroyo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called \u201chyperthecosis.\u201d","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet Gynecol Surv"},{"key":"2019041121392790700_B59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"2019041121392790700_B60","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/jc.2006-1422","article-title":"Prolonged survival in culture of preantral follicles from polycystic ovaries","volume":"92","author":"Webber","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B61","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1210\/jc.2007-0729","article-title":"Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division","volume":"92","author":"Stubbs","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B63","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B64","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041121392790700_B65","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B66","first-page":"1355","article-title":"Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid","volume":"79","author":"Mason","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.humrep.a137638","article-title":"Granulosa cells of polycystic ovaries: are they normal or abnormal?","volume":"7","author":"Erickson","year":"1992","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B68","first-page":"3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","author":"Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B71","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1748-720X.1995.tb01332.x","article-title":"Creating practice guidelines: the dangers of over-reliance on expert judgment","volume":"23","author":"Kane","year":"1995","journal-title":"J Law Med Ethics"},{"key":"2019041121392790700_B73","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/107327480000700411","article-title":"Evidence-based medicine and practice guidelines: an overview","volume":"7","author":"Woolf","year":"2000","journal-title":"Cancer Control"},{"key":"2019041121392790700_B74","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"2019041121392790700_B75","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B76","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/qhc.0100238","article-title":"Formal consensus: the development of a national clinical guideline","volume":"10","author":"Rycroft-Malone","year":"2001","journal-title":"Qual Health Care"},{"key":"2019041121392790700_B77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1215\/03616878-13-3-469","article-title":"Do consensus conferences work? A process evaluation of the NIH Consensus Development Program","volume":"13","author":"Wortman","year":"1988","journal-title":"J Health Polit Policy Law"},{"key":"2019041121392790700_B78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S0266462307070511","article-title":"Impact of the National Institutes of Health Consensus Development Program on stimulating National Institutes of Health-funded research, 1998 to 2001","volume":"23","author":"Portnoy","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"2019041121392790700_B79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9378(83)90023-6","article-title":"Insulin resistance in polycystic ovary syndrome","volume":"147","author":"Shoupe","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"2019041121392790700_B82","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"2019041121392790700_B83","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B84","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B85","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/oxfordjournals.humrep.a137702","article-title":"IVF and the ovarian hyperstimulation syndrome","volume":"7","author":"MacDougall","year":"1992","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B87","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2009.11.017","article-title":"IVF outcome in women with PCOS, PCO and normal ovarian morphology","volume":"149","author":"Swanton","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121392790700_B88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmm034","article-title":"Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation","volume":"14","author":"Fauser","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries","volume":"39","author":"Robinson","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B90","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B91","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","article-title":"Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome","volume":"91","author":"Murphy","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B92","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B93","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/deq310","article-title":"Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist endocrine clinic","volume":"26","author":"Wijeyaratne","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B94","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B95","first-page":"995","article-title":"Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing","volume":"85","author":"Chang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B96","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B97","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B98","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B100","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population","volume":"116","author":"Zhang","year":"2009","journal-title":"BJOG"},{"key":"2019041121392790700_B101","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/humrep\/den433","article-title":"Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria","volume":"24","author":"Goverde","year":"2009","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B103","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B105","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/jc.2008-2771","article-title":"Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population","volume":"94","author":"Mortensen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B107","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries","volume":"93","author":"Franks","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B108","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B109","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B110","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","article-title":"Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women","volume":"84","author":"Carmina","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B111","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B112","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asunci\u00f3n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B113","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2019041121392790700_B114","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jmedgenet-2011-100427","article-title":"Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts","volume":"49","author":"Goodarzi","year":"2012","journal-title":"J Med Genet"},{"key":"2019041121392790700_B115","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B116","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"2019041121392790700_B117","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/0026-0495(94)90018-3","article-title":"Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome","volume":"43","author":"Sorbara","year":"1994","journal-title":"Metabolism"},{"key":"2019041121392790700_B118","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.fertnstert.2005.03.051","article-title":"Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance","volume":"84","author":"Goodarzi","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B119","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.fertnstert.2011.05.002","article-title":"Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study","volume":"96","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B120","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B121","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.diabres.2007.01.063","article-title":"Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome","volume":"77","author":"Park","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041121392790700_B122","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B123","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B124","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jc.2004-0229","article-title":"Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome","volume":"90","author":"Ehrmann","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B126","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B127","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/diabetes.53.9.2353","article-title":"Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors","volume":"53","author":"Gambineri","year":"2004","journal-title":"Diabetes"},{"key":"2019041121392790700_B128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B129","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.fertnstert.2009.11.049","article-title":"The determinants of insulin sensitivity, \u03b2-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome and in women who do not have hyperandrogenism","volume":"94","author":"Luque-Ram\u00edrez","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03345564","article-title":"Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome","volume":"31","author":"Essah","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"2019041121392790700_B131","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B132","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diab.42.10.1462","article-title":"Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women","volume":"42","author":"Dunaif","year":"1993","journal-title":"Diabetes"},{"key":"2019041121392790700_B133","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B134","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.2337\/dc07-S042","article-title":"Diagnosis and classification of diabetes mellitus","volume":"30","author":"American Diabetes Association","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1464-5491.2010.02994.x","article-title":"Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?","volume":"27","author":"Tomlinson","year":"2010","journal-title":"Diabet Med"},{"key":"2019041121392790700_B136","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/diacare.21.3.346","article-title":"The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women","volume":"21","author":"Roumain","year":"1998","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B137","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"JAMA"},{"key":"2019041121392790700_B138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jc.2002-020982","article-title":"Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"88","author":"Taponen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B139","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2019041121392790700_B140","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1542\/peds.2006-2481","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign","volume":"118","author":"American Academy of Pediatrics Committee on Adolescence, American College of Obstetricians and Gynecologists Committee on Adolescent Health Care","year":"2006","journal-title":"Pediatrics"},{"key":"2019041121392790700_B141","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/jc.2003-031720","article-title":"Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"89","author":"Taponen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B142","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0895-4356(00)00240-7","article-title":"Menstrual patterns and risk of adult-onset diabetes mellitus","volume":"53","author":"Cooper","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"2019041121392790700_B143","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.fertnstert.2010.03.044","article-title":"Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes","volume":"94","author":"Gast","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B144","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019041121392790700_B146","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"2019041121392790700_B147","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B148","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.maturitas.2004.09.005","article-title":"Polycystic ovary syndrome in post-menopausal women\u2014marker of the metabolic syndrome","volume":"50","author":"Margolin","year":"2005","journal-title":"Maturitas"},{"key":"2019041121392790700_B149","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B150","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","article-title":"Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up","volume":"6","author":"Boudreaux","year":"2006","journal-title":"Curr Diab Rep"},{"key":"2019041121392790700_B152","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.fertnstert.2010.06.036","article-title":"Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome","volume":"95","author":"Pesant","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B153","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B154","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"2019041121392790700_B155","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"key":"2019041121392790700_B156","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/db10-1032","article-title":"Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy","volume":"59","author":"Rizza","year":"2010","journal-title":"Diabetes"},{"key":"2019041121392790700_B157","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2014a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B158","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B159","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.fertnstert.2011.08.035","article-title":"Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome","volume":"96","author":"Velling Magnussen","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987. The triumvirate: \u03b2-cell, muscle, liver. A collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes"},{"key":"2019041121392790700_B161","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2337\/db07-9903","article-title":"Orchestration of glucose homeostasis: from a small acorn to the California oak","volume":"56","author":"Bergman","year":"2007","journal-title":"Diabetes"},{"key":"2019041121392790700_B162","first-page":"E79","article-title":"Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity","volume":"263","author":"Groop","year":"1992","journal-title":"Am J Physiol"},{"key":"2019041121392790700_B163","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1515\/JBCPP.1998.9.2-4.205","article-title":"Central role of the adipocyte in insulin resistance","volume":"9","author":"Bergman","year":"1998","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"2019041121392790700_B164","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/diab.44.9.1038","article-title":"Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin","volume":"44","author":"Rebrin","year":"1995","journal-title":"Diabetes"},{"key":"2019041121392790700_B165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI118846","article-title":"Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs","volume":"98","author":"Rebrin","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B166","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.me.36.020185.002241","article-title":"The molecular mechanism of insulin action","volume":"36","author":"Kahn","year":"1985","journal-title":"Annu Rev Med"},{"key":"2019041121392790700_B167","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/edrv-6-1-45","article-title":"Assessment of insulin sensitivity in vivo","volume":"6","author":"Bergman","year":"1985","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B168","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B169","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13813455.2011.563748","article-title":"Tissue-specificity of insulin action and resistance","volume":"117","author":"Benito","year":"2011","journal-title":"Arch Physiol Biochem"},{"key":"2019041121392790700_B170","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"2019041121392790700_B171","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1464-5491.2009.02894.x","article-title":"Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications","volume":"27","author":"Gerich","year":"2010","journal-title":"Diabet Med"},{"key":"2019041121392790700_B172","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/2121589a0","article-title":"Gluconeogenesis by the human kidney","volume":"212","author":"Aber","year":"1966","journal-title":"Nature"},{"key":"2019041121392790700_B173","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/jappl.1999.87.5.1813","article-title":"Assessment of methods for improving tracer estimation of non-steady-state rate of appearance","volume":"87","author":"Gastaldelli","year":"1999","journal-title":"J Appl Physiol"},{"key":"2019041121392790700_B174","volume-title":"Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis","author":"Wolfe","year":"1992"},{"key":"2019041121392790700_B175","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI110398","article-title":"Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and \u03b2-cell glucose sensitivity from the response to intravenous glucose","volume":"68","author":"Bergman","year":"1981","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B176","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-2607(96)01784-1","article-title":"Estimation of endogenous glucose production after a glucose perturbation by nonparametric stochastic deconvolution","volume":"52","author":"Vicini","year":"1997","journal-title":"Comput Methods Programs Biomed"},{"key":"2019041121392790700_B177","first-page":"E285","article-title":"Glucose production during an IVGTT by deconvolution: validation with the tracer-to-tracee clamp technique","volume":"276","author":"Vicini","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041121392790700_B178","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dmr.5610050501","article-title":"Assessment of insulin sensitivity in vivo: a critical review","volume":"5","author":"Bergman","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"2019041121392790700_B179","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jcem-71-6-1508","article-title":"Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects","volume":"71","author":"Welch","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B180","first-page":"379","article-title":"Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp","volume":"75","author":"Mitrakou","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B181","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2019041121392790700_B182","first-page":"383","article-title":"Fasting glucose to insulin ratio, or product of glucose and insulin?","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B183","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem.87.1.8292","article-title":"Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention","volume":"87","author":"Hreb\u00edcek","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B184","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/oby.2008.336","article-title":"OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself","volume":"16","author":"H\u00fccking","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"2019041121392790700_B185","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B186","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B187","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B188","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0889-8545(05)70188-1","article-title":"Diabetes prevalence and risk factors in polycystic ovary syndrome","volume":"28","author":"Legro","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2019041121392790700_B189","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1210\/jcem-57-2-304","article-title":"Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women","volume":"57","author":"Evans","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B190","first-page":"2198","article-title":"Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women\u2014a clinical research center study","volume":"81","author":"Lovejoy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B191","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJM199603143341107","article-title":"Androgens in men\u2014uses and abuses","volume":"334","author":"Bagatell","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B192","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"2019041121392790700_B193","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-8227(96)80035-0","article-title":"Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease?","volume":"30","author":"Kissebah","year":"1996","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041121392790700_B194","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000182732","article-title":"Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism","volume":"39","author":"Pasquali","year":"1993","journal-title":"Horm Res"},{"key":"2019041121392790700_B195","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0026-0495(94)90118-X","article-title":"Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome","volume":"43","author":"Pasquali","year":"1994","journal-title":"Metabolism"},{"key":"2019041121392790700_B196","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-2007-978680","article-title":"The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adrenal axis in humans","volume":"32","author":"Pasquali","year":"2000","journal-title":"Horm Metab Res"},{"key":"2019041121392790700_B197","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B198","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterises women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B199","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/oby.2011.400","article-title":"Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS","volume":"20","author":"Yalamanchi","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"2019041121392790700_B200","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0026-0495(90)90002-T","article-title":"Obesity and insulin resistance in humans: a dose-response study","volume":"39","author":"Bonadonna","year":"1990","journal-title":"Metabolism"},{"key":"2019041121392790700_B201","first-page":"1052","article-title":"Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance","volume":"78","author":"Holte","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B202","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2019041121392790700_B204","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B205","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/humrep\/12.9.1897","article-title":"Heterogeneity in \u03b2 cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome","volume":"12","author":"Ciampelli","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2008-1492","article-title":"Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance","volume":"94","author":"Ciaraldi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B207","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2005.12.067","article-title":"Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome","volume":"86","author":"Glintborg","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B209","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B210","first-page":"1636","article-title":"Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome","volume":"77","author":"Ovesen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B211","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/jc.2003-031378","article-title":"Insulin sensitivity in women with polycystic ovary syndrome","volume":"89","author":"Vrb\u00edkov\u00e1","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejogrb.2006.10.038","article-title":"Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women","volume":"133","author":"de Paula Martins","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121392790700_B213","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/jc.2003-030219","article-title":"Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome","volume":"88","author":"Ducluzeau","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B214","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/humrep\/dem302","article-title":"Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome","volume":"22","author":"Vigil","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B215","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2006.01.024","article-title":"Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome","volume":"86","author":"Fulghesu","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B216","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/jc.2004-0410","article-title":"Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients","volume":"90","author":"Ciampelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B217","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/humrep\/12.5.905","article-title":"Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound","volume":"12","author":"Carmina","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B218","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B219","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"2019041121392790700_B221","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diab.43.8.1066","article-title":"Insulin action, diabetogenes, and the cause of type 2 diabetes","volume":"43","author":"Kahn","year":"1994","journal-title":"Diabetes"},{"key":"2019041121392790700_B222","first-page":"117","article-title":"Insulin action and the insulin signaling network","volume":"16","author":"Cheatham","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B223","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1016\/S0021-9258(18)34032-8","article-title":"The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor","volume":"257","author":"Kasuga","year":"1982","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B224","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/313756a0","article-title":"Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes","volume":"313","author":"Ullrich","year":"1985","journal-title":"Nature"},{"key":"2019041121392790700_B225","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0092-8674(85)90334-4","article-title":"The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling","volume":"40","author":"Ebina","year":"1985","journal-title":"Cell"},{"key":"2019041121392790700_B226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.7031900","article-title":"Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor","volume":"215","author":"Kasuga","year":"1982","journal-title":"Science"},{"key":"2019041121392790700_B227","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"2019041121392790700_B228","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1016\/S0021-9258(18)33955-3","article-title":"Insulin stimulation of phosphorylation of the \u03b2 subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine","volume":"257","author":"Kasuga","year":"1982","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B229","doi-asserted-by":"crossref","first-page":"18701","DOI":"10.1016\/S0021-9258(18)51524-6","article-title":"Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction","volume":"264","author":"Cobb","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B230","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1021\/bi00245a010","article-title":"Autophosphorylation within insulin receptor \u03b2-subunits can occur as an intramolecular process","volume":"30","author":"Shoelson","year":"1991","journal-title":"Biochemistry"},{"key":"2019041121392790700_B231","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0968-0004(94)90007-8","article-title":"The IRS-1 signaling system","volume":"19","author":"Myers","year":"1994","journal-title":"Trends Biochem Sci"},{"key":"2019041121392790700_B232","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3904\/kjim.2010.25.2.119","article-title":"Molecular mechanism of insulin resistance in obesity and type 2 diabetes","volume":"25","author":"Choi","year":"2010","journal-title":"Korean J Intern Med"},{"key":"2019041121392790700_B233","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/352073a0","article-title":"Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein","volume":"352","author":"Sun","year":"1991","journal-title":"Nature"},{"key":"2019041121392790700_B234","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","article-title":"The role of GSK3 in glucose homeostasis and the development of insulin resistance","volume":"77","author":"Lee","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041121392790700_B235","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B236","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance","volume":"76","author":"Flier","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B237","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.1016\/S0021-9258(17)36885-0","article-title":"Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor","volume":"269","author":"Sasaoka","year":"1994","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B238","doi-asserted-by":"crossref","first-page":"22884","DOI":"10.1074\/jbc.272.36.22884","article-title":"Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation","volume":"272","author":"Berhanu","year":"1997","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B239","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1210\/jcem-54-2-269","article-title":"Cell culture studies on patients with extreme insulin resistance. II. Abnormal biological responses in cultured fibroblasts","volume":"54","author":"Podskalny","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B241","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tem.2010.06.005","article-title":"Insulin signaling meets mitochondria in metabolism","volume":"21","author":"Cheng","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121392790700_B242","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B243","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09687680110076407","article-title":"Intracellular signalling mechanisms regulating glucose transport in insulin-sensitive tissues (Review)","volume":"18","author":"Litherland","year":"2001","journal-title":"Mol Membr Biol"},{"key":"2019041121392790700_B244","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1073\/pnas.83.16.5822","article-title":"Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity","volume":"83","author":"Bollag","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B245","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(18)69090-8","article-title":"Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity","volume":"263","author":"Takayama","year":"1988","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B246","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/db06-0391","article-title":"Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85\u03b1","volume":"55","author":"Draznin","year":"2006","journal-title":"Diabetes"},{"key":"2019041121392790700_B247","first-page":"413","article-title":"Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus","volume":"44","author":"Kruszynska","year":"1996","journal-title":"J Investig Med"},{"key":"2019041121392790700_B248","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diab.40.11.1440","article-title":"Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells","volume":"40","author":"M\u00fcller","year":"1991","journal-title":"Diabetes"},{"key":"2019041121392790700_B249","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"2019041121392790700_B250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/jcem-54-2-261","article-title":"Cell culture studies on patients with extreme insulin resistance. I. Receptor defects on cultured fibroblasts","volume":"54","author":"Podskalny","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B251","first-page":"577","article-title":"Cellular mechanisms of insulin resistance in polycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B252","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/del466","article-title":"Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery","volume":"22","author":"Seow","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B253","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.fertnstert.2007.10.025","article-title":"Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3","volume":"90","author":"Chang","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B254","first-page":"E197","article-title":"Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiol"},{"key":"2019041121392790700_B255","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/dmr.5610050804","article-title":"Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes","volume":"5","author":"Caro","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"2019041121392790700_B256","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jcem-73-4-691","article-title":"Clinical review 26: insulin resistance in obese and nonobese man","volume":"73","author":"Caro","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B257","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1172\/JCI113744","article-title":"Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss","volume":"82","author":"Freidenberg","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B258","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI6928","article-title":"Normal insulin-dependent activation of Akt\/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes","volume":"104","author":"Kim","year":"1999","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B259","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B260","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-020363","article-title":"Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators","volume":"87","author":"Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B261","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121392790700_B262","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/db07-0706","article-title":"Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment","volume":"57","author":"H\u00f8jlund","year":"2008","journal-title":"Diabetes"},{"key":"2019041121392790700_B263","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121392790700_B264","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI116005","article-title":"Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin","volume":"90","author":"Sarabia","year":"1992","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B265","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2337\/diab.44.8.936","article-title":"Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures","volume":"44","author":"Henry","year":"1995","journal-title":"Diabetes"},{"key":"2019041121392790700_B266","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1172\/JCI119046","article-title":"Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action","volume":"98","author":"Thompson","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B267","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121392790700_B268","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/diabetes.55.03.06.db05-0453","article-title":"Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome","volume":"55","author":"Corbould","year":"2006","journal-title":"Diabetes"},{"key":"2019041121392790700_B269","doi-asserted-by":"crossref","first-page":"E1298","DOI":"10.1210\/jc.2011-0278","article-title":"Intact primary mitochondrial function in myotubes established from women with PCOS","volume":"96","author":"Eriksen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B270","doi-asserted-by":"crossref","first-page":"e14469","DOI":"10.1371\/journal.pone.0014469","article-title":"Insulin resistance is not conserved in myotubes established from women with PCOS","volume":"5","author":"Eriksen","year":"2010","journal-title":"PloS One"},{"key":"2019041121392790700_B271","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes","volume":"307","author":"Lowell","year":"2005","journal-title":"Science"},{"key":"2019041121392790700_B272","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/db07-0275","article-title":"Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin resistant women with polycystic ovary syndrome","volume":"56","author":"Skov","year":"2007","journal-title":"Diabetes"},{"key":"2019041121392790700_B273","doi-asserted-by":"crossref","first-page":"e2466","DOI":"10.1371\/journal.pone.0002466","article-title":"Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome","volume":"3","author":"Skov","year":"2008","journal-title":"PloS One"},{"key":"2019041121392790700_B274","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B275","first-page":"1147","article-title":"Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B276","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","article-title":"A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance","volume":"51","author":"Ek","year":"2002","journal-title":"Diabetes"},{"key":"2019041121392790700_B277","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B278","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/BJ20082176","article-title":"Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1\/2 by insulin in skeletal muscle in vivo","volume":"418","author":"Rajkhowa","year":"2009","journal-title":"Biochem J"},{"key":"2019041121392790700_B279","first-page":"49","article-title":"The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model","volume":"24","author":"Bergman","year":"1990","journal-title":"Horm Metab Res Suppl"},{"key":"2019041121392790700_B280","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diab.31.2.132","article-title":"Impaired in vivo insulin clearance in patients with severe target-cell resistance to insulin","volume":"31","author":"Flier","year":"1982","journal-title":"Diabetes"},{"key":"2019041121392790700_B281","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B282","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/deh609","article-title":"Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries","volume":"20","author":"Rice","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B283","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B284","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121392790700_B285","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","article-title":"The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance","volume":"89","author":"Bremer","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B286","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1210\/en.2007-1527","article-title":"Pathways leading to phosphorylation of P450c17 and to the posttranslational regulation of androgen biosynthesis","volume":"149","author":"Tee","year":"2008","journal-title":"Endocrinology"},{"key":"2019041121392790700_B287","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2004-0178","article-title":"Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome","volume":"19","author":"Nelson-Degrave","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019041121392790700_B288","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1074\/jbc.M110508200","article-title":"Active Rho kinase (ROK-\u03b1) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells","volume":"277","author":"Begum","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B289","first-page":"4338","article-title":"Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome","volume":"85","author":"Martens","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","article-title":"The evolution of \u03b2-cell dysfunction and insulin resistance in type 2 diabetes","volume":"32","author":"Bergman","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"2019041121392790700_B291","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81125-3","article-title":"Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance","volume":"92","author":"Kahn","year":"1998","journal-title":"Cell"},{"key":"2019041121392790700_B292","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and \u03b2-cell function in human subjects. Evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"2019041121392790700_B293","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000022865","article-title":"Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators","volume":"49","author":"Watanabe","year":"1999","journal-title":"Hum Hered"},{"key":"2019041121392790700_B294","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","article-title":"Clinical risk factors, DNA variants, and the development of type 2 diabetes","volume":"359","author":"Lyssenko","year":"2008","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B295","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00125-010-1753-5","article-title":"Variants at DGKB\/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated \u03b2 cell function in middle-aged Danish people","volume":"53","author":"Boesgaard","year":"2010","journal-title":"Diabetologia"},{"key":"2019041121392790700_B296","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc10-0165","article-title":"Disposition index, glucose effectiveness, and conversion to type 2 diabetes","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B297","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B298","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B299","first-page":"1241","article-title":"Defects in \u03b2-cell function in functional ovarian hyperandrogenism","volume":"76","author":"O'Meara","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B300","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1210\/edrv-16-3-390","article-title":"Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide","volume":"16","author":"Fehmann","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B301","first-page":"942","article-title":"\u03b2-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B302","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and \u03b2-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B303","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2265.1993.tb01009.x","article-title":"The relation between clinical manifestations of polycystic ovary syndrome and \u03b2-cell function","volume":"38","author":"Weber","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B304","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/humrep\/13.4.847","article-title":"Acute insulin response to intravenous glucagon in polycystic ovary syndrome","volume":"13","author":"Ciampelli","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/jc.2004-1006","article-title":"\u03b2-Cell function: a key pathological determinant in polycystic ovary syndrome","volume":"90","author":"Goodarzi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B306","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B307","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.33549\/physiolres.931493","article-title":"Fasting insulin pulsatile secretion in lean women with polycystic ovary syndrome","volume":"57","author":"Grimmichova","year":"2008","journal-title":"Physiol Res"},{"key":"2019041121392790700_B308","doi-asserted-by":"crossref","first-page":"e11302","DOI":"10.1371\/journal.pone.0011302","article-title":"Androgen excess produces systemic oxidative stress and predisposes to \u03b2-cell failure in female mice","volume":"5","author":"Liu","year":"2010","journal-title":"PloS One"},{"key":"2019041121392790700_B309","first-page":"4420","article-title":"Effects of methyltestosterone on insulin secretion and sensitivity in women","volume":"83","author":"Diamond","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B310","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1210\/jc.2008-1664","article-title":"Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2","volume":"94","author":"Biyasheva","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B311","first-page":"2027","article-title":"Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives","volume":"86","author":"Colilla","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B312","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/S0021-9258(18)89242-0","article-title":"Kinetics of insulin receptor internalization and recycling in adipocytes. Shunting of receptors to a degradative pathway by inhibitors of recycling","volume":"260","author":"Marshall","year":"1985","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B313","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2007-1018996","article-title":"Insulin and C-peptide levels in obese patients with polycystic ovaries","volume":"14","author":"Pasquali","year":"1982","journal-title":"Horm Metab Res"},{"key":"2019041121392790700_B314","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2007-1009272","article-title":"Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease","volume":"21","author":"Mahabeer","year":"1989","journal-title":"Horm Metab Res"},{"key":"2019041121392790700_B315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jcem-64-1-162","article-title":"Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women","volume":"64","author":"Peiris","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B316","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/eje.1.02058","article-title":"Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS","volume":"154","author":"Carmina","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2019041121392790700_B317","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"2019041121392790700_B318","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121392790700_B319","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","article-title":"Abdominal adiposity and the polycystic ovary syndrome","volume":"18","author":"Escobar-Morreale","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121392790700_B320","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2002-021573","article-title":"Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome","volume":"88","author":"Faulds","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B321","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.11.012","article-title":"Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk","volume":"120","author":"Bergman","year":"2007","journal-title":"Am J Med"},{"key":"2019041121392790700_B322","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B323","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"2019041121392790700_B324","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1194\/jlr.R800057-JLR200","article-title":"Adipocyte metabolism and obesity","volume":"50","author":"Attie","year":"2009","journal-title":"J Lipid Res"},{"key":"2019041121392790700_B325","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor \u03b1: a key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes"},{"key":"2019041121392790700_B326","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B327","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor \u03b1 in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"2019041121392790700_B328","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1196\/annals.1365.015","article-title":"Indices of low-grade inflammation in polycystic ovary syndrome","volume":"1092","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"2019041121392790700_B329","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","article-title":"Is PCOS an inflammatory process?","volume":"97","author":"Duleba","year":"2012","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B330","doi-asserted-by":"crossref","first-page":"E765","DOI":"10.1210\/jc.2011-2377","article-title":"Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome","volume":"97","author":"Chazenbalk","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B331","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"BJOG"},{"key":"2019041121392790700_B332","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B333","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)61020-8","article-title":"Reproductive endocrinologic alterations in female asymptomatic obesity","volume":"52","author":"Azziz","year":"1989","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B334","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1992.tb02262.x","article-title":"Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance","volume":"36","author":"Robinson","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B335","first-page":"559","article-title":"Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome","volume":"14","author":"Segal","year":"1990","journal-title":"Int J Obes"},{"key":"2019041121392790700_B336","first-page":"1687","article-title":"Leptin concentrations in the polycystic ovary syndrome","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B337","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.physbeh.2009.02.017","article-title":"Sex differences in the regulation of body weight","volume":"97","author":"Shi","year":"2009","journal-title":"Physiol Behav"},{"key":"2019041121392790700_B338","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2019041121392790700_B339","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590400002300","article-title":"Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome","volume":"19","author":"Hirschberg","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"2019041121392790700_B340","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2003-031583","article-title":"Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition","volume":"89","author":"Moran","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B341","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/ajcn\/86.6.1603","article-title":"Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome","volume":"86","author":"Moran","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2019041121392790700_B342","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.jcp.0000150222.31007.a9","article-title":"Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study","volume":"25","author":"Sundblad","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"2019041121392790700_B343","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/09513590600847421","article-title":"Polycystic ovary syndrome in bulimic women\u2014an evaluation based on the new diagnostic criteria","volume":"22","author":"Naess\u00e9n","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2019041121392790700_B344","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.psyneuen.2007.03.008","article-title":"Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women","volume":"32","author":"Naess\u00e9n","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"2019041121392790700_B345","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jcem-59-4-809","article-title":"Specific insulin binding sites in human ovary","volume":"59","author":"Poretsky","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B346","first-page":"1411","article-title":"Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary","volume":"77","author":"el-Roeiy","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B347","first-page":"1488","article-title":"Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1\u20136 and the localization of their gene products in normal and polycystic ovary syndrome ovaries","volume":"78","author":"el-Roeiy","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B348","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0092-8674(82)90399-3","article-title":"Structural and functional homologies in the receptors for insulin and the insulin-like growth factors","volume":"31","author":"Czech","year":"1982","journal-title":"Cell"},{"key":"2019041121392790700_B349","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF00281982","article-title":"Insulin-like growth factors and insulin: comparative aspects","volume":"28","author":"Froesch","year":"1985","journal-title":"Diabetologia"},{"key":"2019041121392790700_B350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B351","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jcb.240480205","article-title":"Insulin\/IGF-I receptor hybrids: a mechanism for increasing receptor diversity","volume":"48","author":"Moxham","year":"1992","journal-title":"J Cell Biochem"},{"key":"2019041121392790700_B352","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B353","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","article-title":"Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor","volume":"80","author":"Willis","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B354","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B355","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin augmentation of 17\u03b1-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121392790700_B356","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"Willis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B357","first-page":"1318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B358","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B359","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/molehr\/gah066","article-title":"Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries","volume":"10","author":"Yen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"2019041121392790700_B360","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)47243-2","article-title":"Effects of insulin on steroidogenesis in cultured porcine ovarian theca","volume":"40","author":"Barbieri","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B361","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0889-8529(18)30245-7","article-title":"Insulin as an effector of human ovarian and adrenal steroid metabolism","volume":"20","author":"Nestler","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121392790700_B362","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary","volume":"28","author":"Franks","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121392790700_B363","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"2019041121392790700_B364","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cmet.2010.06.010","article-title":"Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor","volume":"12","author":"Brothers","year":"2010","journal-title":"Cell Metabolism"},{"key":"2019041121392790700_B365","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0022-4731(88)90344-5","article-title":"Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease","volume":"31","author":"Micic","year":"1988","journal-title":"J Steroid Biochem"},{"key":"2019041121392790700_B366","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI113864","article-title":"Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome","volume":"83","author":"Dunaif","year":"1989","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B367","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2011-2939","article-title":"Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome","volume":"97","author":"Tosi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B368","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B369","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0039-128X(88)90136-5","article-title":"Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin","volume":"52","author":"Plymate","year":"1988","journal-title":"Steroids"},{"key":"2019041121392790700_B370","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jcem.76.2.8432767","article-title":"Sex hormone-binding globulin: a marker for hyperinsulinemia and\/or insulin resistance?","volume":"76","author":"Nestler","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B371","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0002-9378(90)90698-7","article-title":"Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women","volume":"163","author":"Nestler","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B372","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"2019041121392790700_B373","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B374","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncpendmet0787","article-title":"Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome\u2014a reappraisal","volume":"4","author":"Dunaif","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121392790700_B375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B376","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.fertnstert.2008.08.004","article-title":"Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome","volume":"90","author":"Practice Committee of American Society for Reproductive Medicine","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B377","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B378","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"1","author":"Tang","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121392790700_B379","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 \u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B380","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3\u03b2 -hydroxysteroid dehydrogenase","volume":"276","author":"Arlt","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B381","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1677\/jme.0.0320425","article-title":"Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3\u03b2-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPAR-\u03b3 agonist activity","volume":"32","author":"Arlt","year":"2004","journal-title":"J Mol Endocrinol"},{"key":"2019041121392790700_B382","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1095\/biolreprod66.1.190","article-title":"Putative activation of the peroxisome proliferator-activated receptor \u03b3 impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells","volume":"66","author":"Schoppee","year":"2002","journal-title":"Biol Reprod"},{"key":"2019041121392790700_B383","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B384","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.fertnstert.2008.02.167","article-title":"Insulin resistance directly contributes to androgenic potential within ovarian theca cells","volume":"91","author":"Qu","year":"2009","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B385","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/jcem-69-5-1040","article-title":"Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms","volume":"69","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B386","first-page":"1077","article-title":"Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women","volume":"79","author":"Beer","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B387","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1172\/JCI117487","article-title":"Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans","volume":"94","author":"Nestler","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B388","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)04914-2","article-title":"Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome","volume":"79","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B389","first-page":"881","article-title":"Insulin infusion amplifies 17 \u03b1-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B390","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fertnstert.2006.11.076","article-title":"Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome","volume":"88","author":"Romualdi","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B391","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2007-2656","article-title":"Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women","volume":"93","author":"Lawson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B392","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B393","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1210\/jc.2003-030167","article-title":"Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids","volume":"88","author":"Eagleson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B394","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121392790700_B395","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/35030105","article-title":"IRS-2 pathways integrate female reproduction and energy homeostasis","volume":"407","author":"Burks","year":"2000","journal-title":"Nature"},{"key":"2019041121392790700_B396","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Br\u00fcning","year":"2000","journal-title":"Science"},{"key":"2019041121392790700_B397","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","article-title":"Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility","volume":"11","author":"Hill","year":"2010","journal-title":"Cell Metabolism"},{"key":"2019041121392790700_B398","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/en.2009-0788","article-title":"The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia","volume":"151","author":"Nandi","year":"2010","journal-title":"Endocrinology"},{"key":"2019041121392790700_B399","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0026-0495(84)90229-4","article-title":"Sex and insulin sensitivity","volume":"33","author":"Yki-J\u00e4rvinen","year":"1984","journal-title":"Metabolism"},{"key":"2019041121392790700_B400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/diab.44.1.31","article-title":"Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography","volume":"44","author":"Nuutila","year":"1995","journal-title":"Diabetes"},{"key":"2019041121392790700_B401","first-page":"E211","article-title":"Sex difference in insulin-stimulated glucose transport in rat and human adipocytes","volume":"246","author":"Foley","year":"1984","journal-title":"Am J Physiol"},{"key":"2019041121392790700_B402","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B403","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B404","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jcem-71-3-696","article-title":"The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women","volume":"71","author":"Mortola","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B405","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jcem-66-1-57","article-title":"Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men","volume":"66","author":"Nestler","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B406","first-page":"E851","article-title":"Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats","volume":"262","author":"Holm\u00e4ng","year":"1992","journal-title":"Am J Physiol"},{"key":"2019041121392790700_B407","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2337\/diab.45.5.615","article-title":"Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment","volume":"45","author":"Rincon","year":"1996","journal-title":"Diabetes"},{"key":"2019041121392790700_B408","doi-asserted-by":"crossref","first-page":"e4274","DOI":"10.1371\/journal.pone.0004274","article-title":"Effect of testosterone on insulin stimulated IRS-1 Ser phosphorylation in primary rat myotubes\u2014a potential model for PCOS-related insulin resistance","volume":"4","author":"Allemand","year":"2009","journal-title":"PloS One"},{"key":"2019041121392790700_B409","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manner\u00e5s","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121392790700_B410","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.1.07070","article-title":"Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women","volume":"192","author":"Corbould","year":"2007","journal-title":"J Endocrinol"},{"key":"2019041121392790700_B411","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","article-title":"Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots","volume":"47","author":"Dicker","year":"2004","journal-title":"Diabetologia"},{"key":"2019041121392790700_B412","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biochi.2004.11.012","article-title":"Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome","volume":"87","author":"Arner","year":"2005","journal-title":"Biochimie"},{"key":"2019041121392790700_B413","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","article-title":"Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes","volume":"280","author":"Xu","year":"2005","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B414","first-page":"329","article-title":"Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues","volume":"1","author":"M\u00e5rin","year":"1992","journal-title":"Eur J Med"},{"key":"2019041121392790700_B415","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1210\/jc.2004-0784","article-title":"Effects of androgen therapy on adipose tissue and metabolism in older men","volume":"89","author":"Schroeder","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B416","first-page":"2044","article-title":"Long-term testosterone administration increases visceral fat in female to male transsexuals","volume":"82","author":"Elbers","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B417","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jc.2003-031492","article-title":"Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men","volume":"89","author":"Woodhouse","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B418","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B419","first-page":"4278","article-title":"Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels","volume":"84","author":"Lemieux","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B420","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0026-0495(95)90062-4","article-title":"Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome","volume":"44","author":"Diamanti-Kandarakis","year":"1995","journal-title":"Metabolism"},{"key":"2019041121392790700_B421","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0015-0282(16)56213-X","article-title":"Insulin resistance improves in hyperandrogenic women treated with Lupron","volume":"60","author":"Elkind-Hirsch","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B422","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B423","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/humrep\/14.4.893","article-title":"Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism","volume":"14","author":"Cagnacci","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B424","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B425","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin and their combination added to hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B426","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0002-9378(73)90071-9","article-title":"Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease","volume":"117","author":"Judd","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B427","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0015-0282(16)41539-6","article-title":"Polycystic ovarian disease, maturation arrest of spermiogenesis, and Klinefelter's syndrome in siblings of a family with familial hirsutism","volume":"26","author":"Cohen","year":"1975","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B428","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0889-8529(18)30409-2","article-title":"Familial polycystic ovarian disease","volume":"17","author":"Givens","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121392790700_B429","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0026-0495(86)90201-5","article-title":"Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess","volume":"35","author":"Stuart","year":"1986","journal-title":"Metabolism"},{"key":"2019041121392790700_B430","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B431","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/humrep\/12.12.2641","article-title":"The genetic basis of polycystic ovary syndrome","volume":"12","author":"Franks","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B432","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B433","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","article-title":"Development of polycystic ovary syndrome: involvement of genetic and environmental factors","volume":"29","author":"Franks","year":"2006","journal-title":"Int J Androl"},{"key":"2019041121392790700_B434","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ncpendmet0400","article-title":"The genetics of the polycystic ovary syndrome","volume":"3","author":"Urbanek","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121392790700_B435","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome (PCOS) in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B436","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","article-title":"Evidence for a single gene effect causing polycystic ovaries and male pattern baldness","volume":"38","author":"Carey","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121392790700_B437","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-0760(99)00043-6","article-title":"Heritability and the risk of developing androgen excess","volume":"69","author":"Kashar-Miller","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121392790700_B438","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1126\/science.8091226","article-title":"Genetic dissection of complex traits","volume":"265","author":"Lander","year":"1994","journal-title":"Science"},{"key":"2019041121392790700_B439","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/humupd\/7.4.405","article-title":"Candidate genes in polycystic ovary syndrome","volume":"7","author":"Franks","year":"2001","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B440","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B441","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI111417","article-title":"Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man","volume":"74","author":"Veldhuis","year":"1984","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B442","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B443","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B444","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2004-2217","article-title":"Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome","volume":"90","author":"Sam","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B445","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1073\/pnas.0602025103","article-title":"Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome","volume":"103","author":"Sam","year":"2006","journal-title":"Proc Nat Acad Sci USA"},{"key":"2019041121392790700_B446","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.metabol.2007.08.010","article-title":"Evidence for pancreatic \u03b2-cell dysfunction in brothers of women with polycystic ovary syndrome","volume":"57","author":"Sam","year":"2008","journal-title":"Metabolism"},{"key":"2019041121392790700_B447","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc07-2190","article-title":"Metabolic phenotype in the brothers of women with polycystic ovary syndrome","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B448","first-page":"1979","article-title":"Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome","volume":"81","author":"Talbot","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B449","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fertnstert.2005.12.073","article-title":"Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population","volume":"86","author":"Lee","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B450","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/oxfordjournals.humrep.a138773","article-title":"The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome","volume":"9","author":"Conway","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B451","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1530\/EJE-08-0932","article-title":"Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome","volume":"160","author":"Mukherjee","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2019041121392790700_B452","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0015-0282(02)04241-3","article-title":"A C\/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome","volume":"78","author":"Siegel","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B453","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1007\/s00125-007-0804-z","article-title":"Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS","volume":"50","author":"Barber","year":"2007","journal-title":"Diabetologia"},{"key":"2019041121392790700_B454","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1016\/j.fertnstert.2011.02.050","article-title":"Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B455","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrg1521","article-title":"Genome-wide association studies for common diseases and complex traits","volume":"6","author":"Hirschhorn","year":"2005","journal-title":"Nat Rev Genet"},{"key":"2019041121392790700_B456","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2009.10.013","article-title":"Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis","volume":"99","author":"Ioannidis","year":"2010","journal-title":"Mol Genet Metab"},{"key":"2019041121392790700_B457","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.fertnstert.2011.01.015","article-title":"Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome","volume":"95","author":"Goodarzi","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B458","first-page":"217","article-title":"Phenotype and genotype in polycystic ovary syndrome","volume":"53","author":"Legro","year":"1998","journal-title":"Recent Prog Horm Res"},{"key":"2019041121392790700_B459","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2019041121392790700_B460","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(96)08368-7","article-title":"Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome","volume":"349","author":"Waterworth","year":"1997","journal-title":"Lancet"},{"key":"2019041121392790700_B461","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1210\/jc.2003-031640","article-title":"Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone","volume":"89","author":"Gaasenbeek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B462","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-005-1737-z","article-title":"No association between insulin gene variation and adult metabolic phenotypes in a large Finnish birth cohort","volume":"48","author":"Bennett","year":"2005","journal-title":"Diabetologia"},{"key":"2019041121392790700_B463","first-page":"283","article-title":"Genetic mapping of complex characters","volume-title":"Human molecular genetics 2","author":"Strachan","year":"1999","edition":"2nd ed"},{"key":"2019041121392790700_B464","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B465","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2009-2703","article-title":"Family-based analysis of candidate genes for polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B466","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1210\/jc.2006-0951","article-title":"Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity","volume":"91","author":"Stewart","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B467","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jcem.86.1.7274","article-title":"Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus","volume":"86","author":"Tucci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B468","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0015-0282(02)04570-3","article-title":"Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome","volume":"79","author":"Villuendas","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B469","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/molehr\/gap072","article-title":"Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries","volume":"15","author":"Prodoehl","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"2019041121392790700_B470","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.2007-0761","article-title":"Identification of a PCOS susceptibility variant in fibrillin-3 and association with a metabolic phenotype","volume":"92","author":"Urbanek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B471","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdrc.20000","article-title":"Fine tuning of growth factor signals depends on fibrillin microfibril networks","volume":"72","author":"Charbonneau","year":"2004","journal-title":"Birth Defects Res C Embryo Today"},{"key":"2019041121392790700_B472","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"2019041121392790700_B473","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0945-053X(00)00100-1","article-title":"Fibrillin: from domain structure to supramolecular assembly","volume":"19","author":"Handford","year":"2000","journal-title":"Matrix Biol"},{"key":"2019041121392790700_B474","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygeno.2003.08.023","article-title":"Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues","volume":"83","author":"Corson","year":"2004","journal-title":"Genomics"},{"key":"2019041121392790700_B475","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physiolgenomics.00092.2004","article-title":"Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology","volume":"19","author":"Ramirez","year":"2004","journal-title":"Physiol Genomics"},{"key":"2019041121392790700_B476","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"2019041121392790700_B477","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF\u03b2 family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"2019041121392790700_B478","first-page":"128","article-title":"The structure and function of fibrillin","volume":"192","author":"Reinhardt","year":"1995","journal-title":"Ciba Found Symp"},{"key":"2019041121392790700_B479","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1074\/jbc.M209201200","article-title":"Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences","volume":"278","author":"Charbonneau","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041121392790700_B480","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0303-7207(02)00053-9","article-title":"Recruitment and development of the follicle; the roles of the transforming growth factor-\u03b2 superfamily","volume":"191","author":"Findlay","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121392790700_B481","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.devcel.2005.09.008","article-title":"The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding","volume":"9","author":"Thompson","year":"2005","journal-title":"Dev Cell"},{"key":"2019041121392790700_B482","first-page":"4455","article-title":"Allelic variants of the follistatin gene in polycystic ovary syndrome","volume":"85","author":"Urbanek","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B483","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/molehr\/gal120","article-title":"Polymorphism of the follistatin gene in polycystic ovary syndrome","volume":"13","author":"Jones","year":"2007","journal-title":"Mol Hum Reprod"},{"key":"2019041121392790700_B484","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mrd.1080320204","article-title":"TGF-\u03b2 receptors","volume":"32","author":"Massagu\u00e9","year":"1992","journal-title":"Mol Reprod Dev"},{"key":"2019041121392790700_B485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00235-X","article-title":"Growth and paracrine factors regulating follicular formation and cellular function","volume":"163","author":"McNatty","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121392790700_B486","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/er.2002-0003","article-title":"Genetic analysis of the mammalian transforming growth factor-\u03b2 superfamily","volume":"23","author":"Chang","year":"2002","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B487","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1139\/o02-161","article-title":"TGF-\u03b2 and the Smad signal transduction pathway","volume":"80","author":"Mehra","year":"2002","journal-title":"Biochem Cell Biol"},{"key":"2019041121392790700_B488","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138955706778742759","article-title":"Inhibitors of the TGF-\u03b2 superfamily and their clinical applications","volume":"6","author":"Tsuchida","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"2019041121392790700_B489","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/mend.12.1.0053","article-title":"Overexpression of mouse follistatin causes reproductive defects in transgenic mice","volume":"12","author":"Guo","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2019041121392790700_B490","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/oxfordjournals.humrep.a136246","article-title":"Follistatin concentrations in follicular fluid of normal and polycystic ovaries","volume":"10","author":"Erickson","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B491","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1320363","article-title":"Effect of streptozotocin injection on expression of immunoreactive follistatin and \u03b2 A and \u03b2 B subunits of inhibin\/activin in rat pancreatic islets","volume":"132","author":"Ogawa","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"2019041121392790700_B492","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/dev.125.6.1017","article-title":"Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development","volume":"125","author":"Miralles","year":"1998","journal-title":"Development"},{"key":"2019041121392790700_B493","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI2769","article-title":"Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants","volume":"102","author":"Yamaoka","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041121392790700_B494","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2019041121392790700_B495","first-page":"56","article-title":"Myostatin (GDF-8) as a key factor linking muscle mass and bone structure","volume":"10","author":"Elkasrawy","year":"2010","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2019041121392790700_B496","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mco.0000134365.99523.7f","article-title":"Role of myostatin in metabolism","volume":"7","author":"Gonzalez-Cadavid","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2019041121392790700_B497","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1210\/jc.2005-2361","article-title":"Myostatin is a human placental product that regulates glucose uptake","volume":"91","author":"Mitchell","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B498","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/er.2008-0003","article-title":"Clinical, agricultural, and evolutionary biology of myostatin: a comparative review","volume":"29","author":"Rodgers","year":"2008","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B499","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1210\/jc.2008-2005","article-title":"Role of follistatin in promoting adipogenesis in women","volume":"94","author":"Flanagan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1507\/endocrj.KR-110","article-title":"Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer","volume":"55","author":"Tsuchida","year":"2008","journal-title":"Endocr J"},{"key":"2019041121392790700_B501","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1152\/japplphysiol.01091.2007","article-title":"Transforming growth factor-\u03b2 and myostatin signaling in skeletal muscle","volume":"104","author":"Kollias","year":"2008","journal-title":"J Appl Physiol"},{"key":"2019041121392790700_B502","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21244","article-title":"Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease","volume":"39","author":"Rodino-Klapac","year":"2009","journal-title":"Muscle Nerve"},{"key":"2019041121392790700_B503","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1073\/pnas.0607966104","article-title":"FSTL3 deletion reveals roles for TGF-\u03b2 family ligands in glucose and fat homeostasis in adults","volume":"104","author":"Mukherjee","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B504","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1369\/jhc.2010.956615","article-title":"Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS?","volume":"58","author":"Jordan","year":"2010","journal-title":"J Histochem Cytochem"},{"key":"2019041121392790700_B505","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1096\/fj.11-181099","article-title":"Linkage of regulators of TGF-\u03b2 activity in the fetal ovary to polycystic ovary syndrome","volume":"25","author":"Hatzirodos","year":"2011","journal-title":"FASEB J"},{"key":"2019041121392790700_B506","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"2019041121392790700_B507","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1093\/hmg\/ddm161","article-title":"Successful design and conduct of genome-wide association studies","volume":"16","author":"Amos","year":"2007","journal-title":"Hum Mol Genet"},{"key":"2019041121392790700_B508","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"2019041121392790700_B509","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.1141634","article-title":"A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity","volume":"316","author":"Frayling","year":"2007","journal-title":"Science"},{"key":"2019041121392790700_B510","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tips.2007.10.008","article-title":"Genome-wide association scans for type 2 diabetes: new insights into biology and therapy","volume":"28","author":"McCarthy","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"2019041121392790700_B511","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ng2032","article-title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","volume":"39","author":"Rioux","year":"2007","journal-title":"Nat Genet"},{"key":"2019041121392790700_B512","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ng.120","article-title":"Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes","volume":"40","author":"Zeggini","year":"2008","journal-title":"Nat Genet"},{"key":"2019041121392790700_B513","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature02623","article-title":"Mapping complex disease loci in whole-genome association studies","volume":"429","author":"Carlson","year":"2004","journal-title":"Nature"},{"key":"2019041121392790700_B514","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ng1669","article-title":"Efficiency and power in genetic association studies","volume":"37","author":"de Bakker","year":"2005","journal-title":"Nat Genet"},{"key":"2019041121392790700_B515","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg1522","article-title":"Genome-wide association studies: theoretical and practical concerns","volume":"6","author":"Wang","year":"2005","journal-title":"Nat Rev Genet"},{"key":"2019041121392790700_B516","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng1337","article-title":"The effects of human population structure on large genetic association studies","volume":"36","author":"Marchini","year":"2004","journal-title":"Nat Genet"},{"key":"2019041121392790700_B517","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1371\/journal.pgen.0030236","article-title":"Discerning the ancestry of European Americans in genetic association studies","volume":"4","author":"Price","year":"2008","journal-title":"PLoS Genet"},{"key":"2019041121392790700_B518","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrg2344","article-title":"Genome-wide association studies for complex traits: consensus, uncertainty and challenges","volume":"9","author":"McCarthy","year":"2008","journal-title":"Nat Rev Genet"},{"key":"2019041121392790700_B519","doi-asserted-by":"crossref","first-page":"37","DOI":"10.31887\/DCNS.2010.12.1\/aneed","article-title":"Whole genome association studies in complex diseases: where do we stand?","volume":"12","author":"Need","year":"2010","journal-title":"Dialogues Clin Neurosci"},{"key":"2019041121392790700_B520","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"2019041121392790700_B521","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMp0806284","article-title":"Common genetic variation and human traits","volume":"360","author":"Goldstein","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B522","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg2779","article-title":"Uncovering the roles of rare variants in common disease through whole-genome sequencing","volume":"11","author":"Cirulli","year":"2010","journal-title":"Nat Rev Genet"},{"key":"2019041121392790700_B523","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMp0808934","article-title":"Genomewide association studies\u2014illuminating biologic pathways","volume":"360","author":"Hirschhorn","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041121392790700_B524","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"key":"2019041121392790700_B525","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/gepi.20292","article-title":"Genome-wide significance for dense SNP and resequencing data","volume":"32","author":"Hoggart","year":"2008","journal-title":"Genet Epidemiol"},{"key":"2019041121392790700_B526","first-page":"599","article-title":"Involvement of ALF in human spermatogenesis and male infertility","volume":"17","author":"Huang","year":"2006","journal-title":"Int J Mol Med"},{"key":"2019041121392790700_B527","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1089\/thy.2006.16.1091","article-title":"Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin","volume":"16","author":"Drieschner","year":"2006","journal-title":"Thyroid"},{"key":"2019041121392790700_B528","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1073\/pnas.0307349101","article-title":"Down-regulation of DENN\/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons","volume":"101","author":"Del Villar","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121392790700_B529","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ng.937","article-title":"Bayesian inference of ancient human demography from individual genome sequences","volume":"43","author":"Gronau","year":"2011","journal-title":"Nat Genet"},{"key":"2019041121392790700_B530","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/505436","article-title":"A geographically explicit genetic model of worldwide human-settlement history","volume":"79","author":"Liu","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2019041121392790700_B531","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature10231","article-title":"Inference of human population history from individual whole-genome sequences","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"2019041121392790700_B532","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"2019041121392790700_B533","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1071\/RD04092","article-title":"Early origins of polycystic ovary syndrome","volume":"17","author":"Dumesic","year":"2005","journal-title":"Reprod Fertil Dev"},{"key":"2019041121392790700_B534","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ajp.20679","article-title":"Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys","volume":"71","author":"Abbott","year":"2009","journal-title":"Am J Primatol"},{"key":"2019041121392790700_B535","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B536","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1152\/ajpendo.90208.2008","article-title":"Transient prenatal androgen exposure produces metabolic syndrome in adult female rats","volume":"295","author":"Demissie","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121392790700_B537","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1095\/biolreprod.105.039800","article-title":"Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator","volume":"72","author":"Foecking","year":"2005","journal-title":"Biol Reprod"},{"key":"2019041121392790700_B538","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1095\/biolreprod.108.067702","article-title":"Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys","volume":"79","author":"Abbott","year":"2008","journal-title":"Biol Reprod"},{"key":"2019041121392790700_B539","first-page":"293","article-title":"Prenatal androgen treatment alters body composition and glucose homeostasis in male rats","volume":"208","author":"Lazic","year":"2011","journal-title":"J Endocrinol"},{"key":"2019041121392790700_B540","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1210\/en.2008-0785","article-title":"Prenatal testosterone excess reduces sperm count and motility","volume":"149","author":"Recabarren","year":"2008","journal-title":"Endocrinology"},{"key":"2019041121392790700_B541","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4067\/S0716-97602007000400007","article-title":"Prenatal testosterone treatment alters LH and testosterone responsiveness to GnRH agonist in male sheep","volume":"40","author":"Recabarren","year":"2007","journal-title":"Biol Res"},{"key":"2019041121392790700_B542","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1210\/jc.2004-0918","article-title":"Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys","volume":"89","author":"Bruns","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B543","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/jc.2007-2256","article-title":"Metabolic profile in sons of women with polycystic ovary syndrome","volume":"93","author":"Recabarren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B544","first-page":"1328","article-title":"Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B545","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","author":"Sir-Petermann","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B546","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9378(79)90649-5","article-title":"Maternal and amniotic fluid steroids throughout human pregnancy","volume":"134","author":"Nagamani","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121392790700_B547","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1210\/jc.2009-2651","article-title":"Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels","volume":"95","author":"Anderson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B548","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1210\/jc.2006-0641","article-title":"Human fetal ovary development involves the spatiotemporal expression of p450c17 protein","volume":"91","author":"Cole","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B549","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/01443615.2010.485254","article-title":"Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels","volume":"30","author":"Barry","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"2019041121392790700_B550","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1210\/jc.2009-0544","article-title":"The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study","volume":"94","author":"Hickey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B551","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00400248","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis","volume":"35","author":"Hales","year":"1992","journal-title":"Diabetologia"},{"key":"2019041121392790700_B552","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1357-4310(95)90793-9","article-title":"Intrauterine programming of adult disease","volume":"1","author":"Barker","year":"1995","journal-title":"Mol Med Today"},{"key":"2019041121392790700_B553","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0301-2115(98)00060-8","article-title":"Maternal regulation of fetal development and health in adult life","volume":"78","author":"Godfrey","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121392790700_B554","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1079\/PHN2001145","article-title":"Fetal programming and adult health","volume":"4","author":"Godfrey","year":"2001","journal-title":"Public Health Nutr"},{"key":"2019041121392790700_B555","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0303-7207(01)00634-7","article-title":"Fetal programming of appetite and obesity","volume":"185","author":"Breier","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121392790700_B556","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2008.06.020","article-title":"Fetal programming of glucose-insulin metabolism","volume":"297","author":"Jones","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121392790700_B557","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1096-9136(199703)14:3<189::AID-DIA325>3.0.CO;2-3","article-title":"The thrifty phenotype hypothesis: how does it look after 5 years?","volume":"14","author":"Hales","year":"1997","journal-title":"Diabet Med"},{"key":"2019041121392790700_B558","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tem.2005.08.004","article-title":"Developmental origins of adult metabolic disease: concepts and controversies","volume":"16","author":"Simmons","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121392790700_B559","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1079\/PNS19980016","article-title":"Maternal nutrition, placental growth and fetal programming","volume":"57","author":"Godfrey","year":"1998","journal-title":"Proc Nutr Soc"},{"key":"2019041121392790700_B560","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.318.7188.885","article-title":"Ordeals for the fetal programming hypothesis. The hypothesis largely survives one ordeal but not another","volume":"318","author":"Susser","year":"1999","journal-title":"BMJ"},{"key":"2019041121392790700_B561","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2337\/diab.40.2.S121","article-title":"Long-term prospective evaluation of offspring of diabetic mothers","volume":"40","author":"Silverman","year":"1991","journal-title":"Diabetes"},{"key":"2019041121392790700_B562","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/diacare.18.5.611","article-title":"Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism","volume":"18","author":"Silverman","year":"1995","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B563","first-page":"21","article-title":"The intrauterine environment: implications for the offspring of diabetic mothers","volume":"4","author":"Silverman","year":"1996","journal-title":"Diabetes Rev"},{"key":"2019041121392790700_B564","first-page":"B142","article-title":"Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center","volume":"21","author":"Silverman","year":"1998","journal-title":"Diabetes Care"},{"key":"2019041121392790700_B565","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2004.079756","article-title":"Experimental models of developmental programming: consequences of exposure to an energy rich diet during development","volume":"565","author":"Armitage","year":"2005","journal-title":"J Physiol (Lond)"},{"key":"2019041121392790700_B566","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"key":"2019041121392790700_B567","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03350781","article-title":"Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset","volume":"21","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2019041121392790700_B568","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/eje.1.02200","article-title":"Maternal testosterone levels during pregnancy are associated with offspring size at birth","volume":"155","author":"Carlsen","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2019041121392790700_B569","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/dei009","article-title":"Birth weight in offspring of mothers with polycystic ovarian syndrome","volume":"20","author":"Sir-Petermann","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B570","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: identifying children at risk for polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B571","first-page":"671","article-title":"Premature adrenarche\u2014normal variant or forerunner of adult disease?","volume":"21","author":"Ib\u00e1\u00f1ez","year":"2000","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B572","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Iba\u00f1ez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B573","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B574","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.metabol.2008.02.018","article-title":"Low birth weight and later development of insulin resistance and biochemical\/clinical features of polycystic ovary syndrome","volume":"57","author":"Pandolfi","year":"2008","journal-title":"Metabolism"},{"key":"2019041121392790700_B575","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/humrep\/deq162","article-title":"High prevalence of polycystic ovary syndrome in women born small for gestational age","volume":"25","author":"Melo","year":"2010","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B576","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","article-title":"Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms","volume":"27","author":"Laitinen","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121392790700_B577","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1210\/jcem.84.11.6106","article-title":"Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women","volume":"84","author":"Jaquet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B578","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/deg409","article-title":"Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort","volume":"18","author":"Sadrzadeh","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121392790700_B579","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jc.2009-1849","article-title":"Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B580","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/jc.2007-1036","article-title":"Early metabolic derangements in daughters of women with polycystic ovary syndrome","volume":"92","author":"Sir-Petermann","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B581","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B582","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B583","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1210\/jc.2007-0267","article-title":"Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome","volume":"92","author":"Crisosto","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B584","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1210\/jc.2009-0427","article-title":"Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Maliqueo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B585","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fertnstert.2008.04.022","article-title":"Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome","volume":"92","author":"Maliqueo","year":"2009","journal-title":"Fertil Steril"},{"key":"2019041121392790700_B586","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jc.2007-1958","article-title":"Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study","volume":"93","author":"Kent","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B587","doi-asserted-by":"crossref","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"key":"2019041121392790700_B588","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/GRF.0b013e31802f3547","article-title":"The metabolic syndrome in polycystic ovary syndrome","volume":"50","author":"Essah","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"2019041121392790700_B589","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121392790700_B590","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"2019041121392790700_B591","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041121392790700_B592","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2019041121392790700_B593","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/GRF.0b013e31803057ed","article-title":"Pregnancy considerations in women with polycystic ovary syndrome","volume":"50","author":"Legro","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"2019041121392790700_B594","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/33\/6\/981\/8860108\/edrv0981.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T21:01:58Z","timestamp":1714683718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/33\/6\/981\/2354926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,12]]},"references-count":594,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,10,12]]},"published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2011-1034","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,12]]}}}